Source link : https://newshealth.biz/health-news/monoclonal-antibody-prevented-relapse-in-adult-onset-nephrotic-syndrome/
(MedPage Today) — Rituximab (Rituxan) prevented relapse in patients with adult-onset frequently relapsing nephrotic syndrome (FRNS) or steroid-dependent nephrotic syndrome (SDNS), a randomized trial showed. Among 66 adults, 87.4% of those treated… Source link : https://www.medpagetoday.com/nephrology/generalnephrology/118319 Author : Publish date : 2025-11-05 16:06:00 Copyright for syndicated content belongs to the linked Source.
The post Monoclonal Antibody Prevented Relapse in Adult-Onset Nephrotic Syndrome first appeared on News Health.
—-
Author : News Health
Publish date : 2025-11-05 16:06:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8